Skip to main content

Advertisement

Log in

Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma

  • Published:
Journal of Biosciences Aims and scope Submit manuscript

Abstract

Although cervical cancer is preventable with early detection, it remains the second most common malignancy among women. An understanding of how proteins change in their expression during a particular diseased state such as cervical cancer will contribute to an understanding of how the disease develops and progresses. Potentially, it may also lead to the ability to predict the occurrence of the disease. With this in mind, we aimed to identify differentially expressed proteins in the plasma of cervical cancer patients. Plasma from control, cervical intraepithelial neoplasia (CIN) grade 3 and squamous cell carcinoma (SCC) stage IV subjects was resolved by two-dimensional gel electrophoresis and the resulting proteome profiles compared. Differentially expressed protein spots were then identified by mass spectrometry. Eighteen proteins were found to be differentially expressed in the plasma of CIN 3 and SCC stage IV samples when compared with that of controls. Competitive ELISA further validated the expression of cytokeratin 19 and tetranectin. Functional analyses of these differentially expressed proteins will provide further insight into their potential role(s) in cervical cancer-specific monitoring and therapeutics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

2DE:

two-dimensional gel electrophoresis

ACHCA:

α-cyano-4-hydroxycinnamic acid

ANOVA:

analysis of variance

cELISA:

competitive ELISA

CIN:

cervical intraepithelial neoplasia

FIGO:

Federation of International Gynecologists and Obstetricians

HRP:

horseradish peroxidase

IEF:

isoelectric focusing

Ig:

immunoglobulin

MALDI-TOF/TOF MS:

matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry

nCLU:

nuclear form of clusterin

Pap:

Papanicolaou

SCC:

squamous cell carcinoma

sCLU:

secretory form of clusterin

SIL:

squamous intraepithelial lesion

TNF:

tumour necrosis factor

References

  • Alaoui-Jamali M A and Xu Y J 2006 Proteomic technology for biomarker profiling in cancer: an update; J. Zhejiang Univ. Sci. B. 7 411–420

    Article  CAS  PubMed  Google Scholar 

  • Bae S M, Lee C H, Cho Y L, Nam K H, Kim Y W, Kim C K, Han B D, Lee Y J et al. 2005 Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients; Gynecol. Oncol. 99 26–35

    Article  CAS  PubMed  Google Scholar 

  • Barak V, Goike H, Panaretakis K W and Einarsson R 2004 Clinical utility of cytokeratins as tumor markers; Clin. Biochem. 37 529–540

    Article  CAS  PubMed  Google Scholar 

  • Chen X, Halberg R B, Ehrhardt W M, Torrealba J and Dov, W F 2003 Clusterin as a biomarker in murine and human intestinal neoplasia; Pro.c Natl. Acad. Sci. USA 100 9530–9535

    Article  CAS  Google Scholar 

  • Coulombe P A and Omary M B 2002 ’Hard’ and ’soft’ principles defining the structure, function and regulation of keratin intermediate filaments; Curr. Opin. Cell Biol. 14 110–122

    Article  CAS  PubMed  Google Scholar 

  • Criswell T, Klokov D, Beman M, Lavik J P and Boothman D A 2003 Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein; Cancer Biol. Ther. 2 372–380

    CAS  PubMed  Google Scholar 

  • Doustjalali S R, Yusof R, Yip C H, Looi L M, Pillay B and Hashim O H 2004 Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors; Electrophoresis 25 2392–2401

    Article  CAS  PubMed  Google Scholar 

  • Ferrero S, Gillott D J, Remorgida V, Anserini P, Price K, Ragni N and Grudzinskas J G 2005 Haptoglobin beta chain isoforms in the plasma and peritoneal fluid of women with endometriosis; Fertil. Steril. 83 1536–1543

    Article  CAS  PubMed  Google Scholar 

  • Gianazza E, Eberini I, Villa P, Fratelli M, Pinna C, Wait R, Gemeiner M and Miller I 2002 Monitoring the effects of drug treatment in rat models of disease by serum protein analysis; J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 771 107–130

    Article  CAS  PubMed  Google Scholar 

  • Hogdall C K, Christiansen M, Norgaard-Pedersen B, Bentzen S M, Kronborg O and Clemmensen I 1995 Plasma tetranectin and colorectal cancer; Eur. J. Cancer 31A 888–894

    Article  CAS  PubMed  Google Scholar 

  • Holtet T L, Graversen J H, Clemmensen I, Thogersen H C and Etzerodt M 1997 Tetranectin, a trimeric plasminogen-binding C-type lectin; Protein Sci. 6 1511–1515

    Article  CAS  PubMed  Google Scholar 

  • Itahara Y, Piens M, Sumida T, Fong S, Maschler J and Desprez P Y 2007 Regulation of clusterin expression in mammary epithelial cells; Exp. Cell Res. 313 943–951

    Article  Google Scholar 

  • Kang Y K, Hong S W, Lee H and Kim W H 2004 Overexpression of clusterin in human hepatocellular carcinoma; Hum. Pathol. 35 1340–1346

    Article  CAS  PubMed  Google Scholar 

  • Kurahashi T, Muramaki M, Yamanaka K, Hara I and Miyake, H 2005 Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension; BJU Int. 96 895–899

    Article  CAS  PubMed  Google Scholar 

  • Marceau N, Schutte B, Gilbert S, Loranger A, Henfling M E, Broers J L, Mathew J and Ramaekers F C 2007 Dual roles of intermediate filaments in apoptosis; Exp. Cell Res. 313 2265–2281

    Article  CAS  PubMed  Google Scholar 

  • Mogues T, Etzerodt M, Hall C, Engelich G, Graversen J H and Hartshorn K L 2004 Tetranectin binds to the kringle 1–4 form of angiostatin and modifies its functional activity; J. Biomed. Biotechnol. 2004 73–78

    Article  PubMed  Google Scholar 

  • MOH 1999 National health and morbidity survey 1996 (Malaysia: Ministry of Health)

    Google Scholar 

  • Nijhuis E R, Reesink-Peters N, Wisman G B, Nijman H W, van Zanden J, Volders H, Hollema H, Suurmeijer A J et al. 2006 An overview of innovative techniques to improve cervical cancer screening; Cell Oncol. 28 233–246

    PubMed  Google Scholar 

  • Oshima R G 2002 Apoptosis and keratin intermediate filaments; Cell Death Differ. 9 486–492

    Article  CAS  PubMed  Google Scholar 

  • Pawlik T M, Hawke D H, Liu Y, Krishnamurthy S, Fritsche H, Hunt K K and Kuerer H M 2006 Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein; BMC Cancer 6 68

    Article  PubMed  Google Scholar 

  • Petignat P and Roy M 2007 Diagnosis and management of cervical cancer; BMJ 335 765–768

    Article  PubMed  Google Scholar 

  • Pins M R, Fiadjoe J E, Korley F, Wong M, Rademaker A W, Jovanovic B, Yoo T K, Kozlowski J M et al. 2004 Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report; Prostate Cancer Prostatic Dis. 7 243–248

    Article  CAS  PubMed  Google Scholar 

  • Reddington J J, Reddington G M and MacLachlan N J 1991 A competitive ELISA for detection of antibodies to the group antigen of bluetongue virus; J. Vet. Diagn. Invest. 3 144–147

    CAS  PubMed  Google Scholar 

  • Shannan B, Seifert M, Boothman D A, Tilgen W and Reichrath J 2006 Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control; J. Mol. Histol. 37 183–188

    Article  CAS  PubMed  Google Scholar 

  • Shepherd J H 1996 Cervical and vulva cancer: changes in FIGO definitions of staging; Br. J. Obstet. Gynaecol. 103 405–406

    CAS  PubMed  Google Scholar 

  • Somiari R I, Somiari S, Russell S and Shriver C D 2005 Proteomics of breast carcinoma; J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 815 215–225

    Article  CAS  PubMed  Google Scholar 

  • Thomas-Tikhonenko A, Viard-Leveugle I, Dews M, Wehrli P, Sevignani C, Yu D, Ricci S, el-Deiry W et al. 2004 Myctransformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo; Cancer Res. 64 3126–3136

    Article  CAS  PubMed  Google Scholar 

  • Tjalma W A, Van Waes T R, Van den Eeden, L E and Bogers J J 2005 Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix; Best Pract. Res. Clin. Obstet. Gynaecol. 19 469–483

    Article  CAS  PubMed  Google Scholar 

  • Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, Hai S, Ono K et al. 2006 Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma; J. Hepatobiliary Pancreat. Surg. 13 239–244

    Article  PubMed  Google Scholar 

  • Winarti A Shame, anxiety keep women from taking Pap test The Jakarta Post 17 March 2008

  • Xin Z Y, Yu Z G, Wang T C, Hui X, Gou W L, Sun J, Qi H and Li R X 2005 Identification and quantification of the toxic dinoflagellate Gymnodinium sp. with competitive enzymelinked immunosorbent assay (cELISA); Harmful Algae 4 297–307

    Article  Google Scholar 

  • Yan J X, Wait R, Berkelman T, Harry R A, Westbrook J A, Wheeler C H and Dunn M J 2000 A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry; Electrophoresis 21 3666–3672

    Article  CAS  PubMed  Google Scholar 

  • Ye B, Cramer D W, Skates S J, Gygi S P, Pratomo V, Fu L, Horick N K, Licklider L J et al. 2003 Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry; Clin. Cancer Res. 9 2904–2911

    CAS  PubMed  Google Scholar 

  • Yong P H, Junit S M, Harun F and Hashim O H 2006 Patients with congenital hypothyroidism demonstrate different altered expression of plasma fibrinogen and haptoglobin polypeptide chains; Clin. Biochem. 39 126–132

    Article  CAS  PubMed  Google Scholar 

  • Yuan C C, Huang H C, Tsai L C, Ng H T and Huang T S 1997 Cytokeratin-19 associated with apoptosis and chemosensitivity in human cervical cancer cells; Apoptosis 2 101–105

    Article  CAS  PubMed  Google Scholar 

  • Yuan C C, Huang T S, Ng H T, Liu R S, Hung M W and Tsai L C 1998 Elevated cytokeratin-19 expression associated with apoptotic resistance and malignant progression of human cervical carcinoma; Apoptosis 3 161–169

    Article  CAS  PubMed  Google Scholar 

  • Zhao C, Annamalai L, Guo C, Kothandaraman N, Koh S C, Zhang H, Biswas A and Choolani M 2007 Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer; Neoplasia 9 1–7

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasmin Anum Mohd Yusof.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Looi, M.L., Karsani, S.A., Rahman, M.A. et al. Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma. J Biosci 34, 917–925 (2009). https://doi.org/10.1007/s12038-009-0106-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12038-009-0106-3

Keywords

Navigation